X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TEVA PHARMA (Israel) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
TEVA PHARMA
Dec-13
ALEMBIC LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs723,001-   
Low Rs342,607-   
Sales per share (Unadj.) Rs4.71,722.1-  
Earnings per share (Unadj.) Rs6.1107.6-  
Cash flow per share (Unadj.) Rs6.2246.8-  
Dividends per share (Unadj.) Rs0.2094.18-  
Dividend yield (eoy) %0.43.4 11.2%  
Book value per share (Unadj.) Rs40.71,913.0-  
Shares outstanding (eoy) m267.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.6 691.9%   
Avg P/E ratio x8.726.1 33.3%  
P/CF ratio (eoy) x8.511.4 74.6%  
Price / Book Value ratio x1.31.5 88.9%  
Dividend payout %3.387.5 3.7%   
Avg Mkt Cap Rs m14,1392,377,546 0.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM32,492.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,029.8-  
INCOME DATA
Net Sales Rs m1,2551,460,373 0.1%  
Other income Rs m3700-   
Total revenues Rs m1,6251,460,373 0.1%   
Gross profit Rs m111399,924 0.0%  
Depreciation Rs m38118,043 0.0%   
Interest Rs m228,684 0.0%   
Profit before tax Rs m442253,197 0.2%   
Minority Interest Rs m01,150 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-166,210 0.0%   
Tax Rs m24-3,091 -0.8%   
Profit after tax Rs m1,63091,228 1.8%  
Gross profit margin %8.927.4 32.3%  
Effective tax rate %5.4-1.2 -444.0%   
Net profit margin %129.86.2 2,078.6%  
BALANCE SHEET DATA
Current assets Rs m1,867986,331 0.2%   
Current liabilities Rs m591860,164 0.1%   
Net working cap to sales %101.68.6 1,176.6%  
Current ratio x3.21.1 275.4%  
Inventory Days Days9491 103.8%  
Debtors Days Days7496 76.7%  
Net fixed assets Rs m1,791476,990 0.4%   
Share capital Rs m5343,595 14.9%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8581,622,198 0.7%   
Long term debt Rs m41746,721 0.0%   
Total assets Rs m11,5913,337,421 0.3%  
Interest coverage x260.99.8 2,654.7%   
Debt to equity ratio x00.5 0.8%  
Sales to assets ratio x0.10.4 24.7%   
Return on assets %14.13.6 391.8%  
Return on equity %15.05.6 266.9%  
Return on capital %15.24.9 308.0%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236232,708 0.1%  
From Investments Rs m-224-82,458 0.3%  
From Financial Activity Rs m-27-279,149 0.0%  
Net Cashflow Rs m-15-128,899 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare ALEMBIC LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALEMBIC LTD With: AJANTA PHARMA  SUN PHARMA  ORCHID PHARMA LTD  UNICHEM LAB  BIOCON LTD  



Today's Market

Sensex Ends 317 Points Higher; Realty and FMCG Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day on a strong note. Gains were largely seen in the realty sector and FMCG sector.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Nov 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS